- Home
- UIS vs NVCT Comparison
UIS vs NVCT Comparison
Compare UIS & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UIS
- NVCT
- Stock Information
- Founded
- UIS 1942
- NVCT 2020
- Country
- UIS United States
- NVCT United States
- Employees
- UIS N/A
- NVCT N/A
- Industry
- UIS EDP Services
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- UIS Technology
- NVCT Health Care
- Exchange
- UIS Nasdaq
- NVCT Nasdaq
- Market Cap
- UIS 271.5M
- NVCT 249.1M
- IPO Year
- UIS N/A
- NVCT 2022
- Fundamental
- Price
- UIS $4.75
- NVCT $9.37
- Analyst Decision
- UIS Hold
- NVCT Strong Buy
- Analyst Count
- UIS 1
- NVCT 3
- Target Price
- UIS $6.50
- NVCT $17.00
- AVG Volume (30 Days)
- UIS 735.5K
- NVCT 132.1K
- Earning Date
- UIS 04-30-2025
- NVCT 05-06-2025
- Dividend Yield
- UIS N/A
- NVCT N/A
- EPS Growth
- UIS N/A
- NVCT N/A
- EPS
- UIS N/A
- NVCT N/A
- Revenue
- UIS $1,952,700,000.00
- NVCT N/A
- Revenue This Year
- UIS N/A
- NVCT N/A
- Revenue Next Year
- UIS $3.79
- NVCT N/A
- P/E Ratio
- UIS N/A
- NVCT N/A
- Revenue Growth
- UIS N/A
- NVCT N/A
- 52 Week Low
- UIS $3.32
- NVCT $4.44
- 52 Week High
- UIS $8.93
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- UIS 47.92
- NVCT 49.95
- Support Level
- UIS $4.71
- NVCT $9.15
- Resistance Level
- UIS $4.98
- NVCT $11.15
- Average True Range (ATR)
- UIS 0.22
- NVCT 0.60
- MACD
- UIS -0.08
- NVCT -0.06
- Stochastic Oscillator
- UIS 4.64
- NVCT 45.12
About UIS Unisys Corporation New
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.